跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,550 条关于
“Cullgen Inc”
全部
41,550
临床试验
11,824
药物
1,626
机构
6,170
资讯
21,930
去年
Cullgen Launches Phase 1 Trial of Novel Non-Opioid Pain Treatment Using Protein Degradation Technology
6个月前
Gyre Therapeutics Acquires Cullgen for $300M to Expand Protein Degradation Platform
去年
Cullgen Completes Phase 1 Enrollment for Novel Non-Opioid Pain Therapy CG001419
9个月前
Pulmatrix and Cullgen Mutually Waive No-Solicitation Clause While Awaiting Chinese Regulatory Approval for Merger
去年
Pulmatrix to Divest Phase 2-Ready Migraine Treatment and iSPERSE Technology Ahead of Cullgen Merger
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
去年
IDEAYA Biosciences, Inc. (IDYA) BCG Matrix Analysis 2024
2年前
Immix Biopharma's NXC-201 Shows Promise as Outpatient CAR-T Therapy in Amyloidosis and Multiple Myeloma
第 1 页,共 2193 页
上一页
下一页